Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 51.11

-2.1%

Nov 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (3287)	4/2/2001 11:26:47 AM
From: nigel bates	Read Replies (4) of 52153

Random thoughts.... CRGN/(and eg)ABGX would be a pretty nice fit. Arguing the relative valuation could be an issue. Depending on the structure of the deal, it could run into problems with shorts (cf Shire). Then there's the question of who'd run the show... and the less than auspicious example of CRXA/CLTR. The right merger would make enormous sense, but I don't expect too many to happen anytime soon. I can't see to many ceos wanting to sell out at current valuations if they're not in cash trouble. (I certainly wouldn't be very happy if eg TELK put itself up for sale now...). Do hostile takeovers happen much in biotech ? Might be a good time for the bigger fish to snap up some minnows - how much value is left if the employees walk though ? nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next